Another New Drug Proves Unsafe

The other day a pharmaceutical representative stopped me in the hall with a somber expression on his face. His drugs, Valturna and Tekturna had just been proven potentially unsafe because of increased stroke and kidney failure rates in diabetics, exactly the target group they were marketed for.

“That’s why I hadn’t prescribed them yet, not enough outcomes data…”

“I know”, he muttered.

PharmaLive: Novartis Announces Termination of ALTITUDE Study With Rasilez/ Tekturna in High-Risk Patients With Diabetes and Renal Impairment.

via PharmaLive: Novartis Announces Termination of ALTITUDE Study With Rasilez/ Tekturna in High-Risk Patients With Diabetes and Renal Impairment.

And the law firms are already on it, before most doctors…